BOTTA, CIRINO
 Distribuzione geografica
Continente #
NA - Nord America 725
AS - Asia 396
EU - Europa 233
Continente sconosciuto - Info sul continente non disponibili 53
SA - Sud America 49
AF - Africa 12
OC - Oceania 3
Totale 1.471
Nazione #
US - Stati Uniti d'America 694
SG - Singapore 203
IT - Italia 124
CN - Cina 75
BR - Brasile 37
VN - Vietnam 30
IN - India 27
HK - Hong Kong 24
GB - Regno Unito 23
CA - Canada 17
DE - Germania 17
SE - Svezia 12
NL - Olanda 11
ES - Italia 8
RU - Federazione Russa 8
FI - Finlandia 7
IQ - Iraq 7
PL - Polonia 7
BD - Bangladesh 6
FR - Francia 5
IL - Israele 5
JP - Giappone 5
MX - Messico 5
EU - Europa 4
SC - Seychelles 4
AR - Argentina 3
CL - Cile 3
CZ - Repubblica Ceca 3
RS - Serbia 3
TR - Turchia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EC - Ecuador 2
ID - Indonesia 2
KE - Kenya 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PR - Porto Rico 2
SA - Arabia Saudita 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.423
Città #
San Jose 132
Singapore 104
Ashburn 71
Chandler 47
Dallas 44
Santa Clara 37
Council Bluffs 28
Hong Kong 24
Milan 23
Hefei 21
Bengaluru 20
Chicago 16
London 16
Ho Chi Minh City 14
Princeton 13
Lawrence 12
Beijing 11
Munich 11
São Paulo 9
Catanzaro 8
New York 8
Los Angeles 7
Naples 7
Boardman 6
Ottawa 6
Phoenix 6
Rome 6
Montreal 5
Tokyo 5
Turku 5
Wilmington 5
Chennai 4
Des Moines 4
Lamezia Terme 4
Redmond 4
Seattle 4
Utrecht 4
Amsterdam 3
Barcelona 3
Bari 3
Brooklyn 3
Castrovillari 3
Denver 3
Hanoi 3
Mexico City 3
Palermo 3
Redwood City 3
Rende 3
Rosarno 3
San Antonio 3
San Nicola Manfredi 3
Shanghai 3
The Dalles 3
Warsaw 3
Baghdad 2
Baku 2
Basra 2
Charlotte 2
Cortale 2
Da Nang 2
Dhaka 2
Grottaglie 2
Helsinki 2
Johannesburg 2
Kansas City 2
Leawood 2
Manchester 2
Markham 2
Nairobi 2
Nuremberg 2
Olomouc 2
Orem 2
Padova 2
Salt Lake City 2
Salvador 2
San Francisco 2
Santiago 2
Santo Stefano di Rogliano 2
Shenzhen 2
Tashkent 2
Thái Bình 2
Toronto 2
Turin 2
Washington 2
Abbeville 1
Acri 1
Adamantina 1
Agrestina 1
Alagoinhas 1
Amargosa 1
Atlanta 1
Auckland 1
Austin 1
Bad Nauheim 1
Ballwin 1
Barquisimeto 1
Bauru 1
Beautiran 1
Birmingham 1
Bismarck 1
Totale 878
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 116
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 94
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 90
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 87
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 86
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 82
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 81
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 76
Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response 74
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 71
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 71
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma 68
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma 66
Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report 64
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 58
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 56
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 55
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies 49
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology 49
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 44
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells 34
Totale 1.471
Categoria #
all - tutte 11.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 7 2 7 9 8 9 13 0
2022/2023151 25 16 16 5 12 14 6 7 26 7 13 4
2023/2024104 24 13 5 18 9 19 0 0 3 2 2 9
2024/2025294 29 7 10 19 21 42 13 13 29 4 41 66
2025/2026592 37 70 52 42 59 31 106 38 64 64 20 9
2026/2027202 2 39 61 61 39 0 0 0 0 0 0 0
Totale 1.471